Lilly antibody treatment lands FDA Emergency Use Authorization

The U.S. Food and Drug Administration has granted an Emergency Use Authorization for a COVID-19 antibody therapy developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY).

Lilly reaches agreement with government for COVID treatment

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has reached an initial agreement with the U.S. government to supply 300,000 vials of its investigational antibody treatment for COVID-19.

Applications open for Indy hospitality grant program

The city of Indianapolis has begun accepting applications for a grant program designed to help local restaurants, bars, and entertainment venues

Lilly details COVID treatment manufacturing partnership

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Amgen Inc. (Nasdaq: AMGN) are collaborating on the manufacturing of potential COVID-19 therapies.

Study: Asymptomatic COVID infection possible in kids

A recently-completed study from the Indiana University School of Medicine shows asymptomatic COVID-19 infection is possible in children under the age of 10.

GM to give control of Kokomo plant to Ventec

General Motors Co. (NYSE: GM) says it will soon hand over operational control of its Kokomo plant to Washington-based Ventec Life Systems.